David Baxley Spetzler serves as Executive at Caris Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, David Baxley Spetzler has executed 2 insider transactions totaling $9.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 7, 2025 involved purchasing 400 shares valued at $9.5K.
David Baxley Spetzler currently holds 460,777 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Baxley Spetzler has been a net buyer of CAI stock. They have purchased $9.5K and sold $0 worth of shares.
David Baxley Spetzler's most recent insider trade was on Nov 7, 2025, when they purchased 400 shares at $23.85 per share.
Get notified when new Form 4 filings are submitted
| $29.75 |
| Discretionary |